Thoughtful Story on the Cells=Drugs Controversy
Orthopedics this Week and Walter Eisner did a great job exploring the pros and cons of the FDA considering our Regenexx-C procedure a drug (which forced us to move that procedure to the Cayman Islands). It’s a balanced read on the cells=drugs controversy, here’s the link to the full story “Stem Cell Therapies: Clinical Practice or a Drug?” Here’s the link to the story at the OTW site.
If you have questions or comments about this blog post, please email us at [email protected]
NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.